1 INTRODUCTION

In the past few years, and with COVID‐19 most recently, we have been reminded of the importance of robust public health monitoring programs as they relate to birth defects surveillance, research, and prevention. With the never‐ending appearance of new exposures—such as novel medications, infections, vaccines, chemicals, herbal products, and substances of abuse— it is vital that public health agencies are sufficiently prepared to evaluate the impact of these exposures on the occurrence of birth defects and to evaluate the presence of new birth defect syndromes. A multidisciplinary approach is needed to not only conduct birth defects surveillance but also to mitigate the impact of birth defects. As an example, in this editorial we propose a framework for a stronger collaboration between National Birth Defect Prevention Network (NBDPN) and the Organization of Teratology Information Specialists (OTIS) with the goal of addressing the impact of novel and existing exposures on the occurrence of birth defects.

中文翻译：

---

促进合作以改善出生缺陷监测、研究和预防：国家出生缺陷预防网络和畸形学信息专家组织的联合社论

1 介绍

在过去几年中，以及最近的 COVID-19，我们被提醒强大的公共卫生监测计划的重要性，因为它们与出生缺陷监测、研究和预防有关。随着新暴露的不断出现——例如新型药物、感染、疫苗、化学品、草药产品和滥用物质——至关重要的是，公共卫生机构必须充分准备好评估这些暴露对发生的影响。出生缺陷并评估新出生缺陷综合征的存在。需要采用多学科方法，不仅要进行出生缺陷监测，还要减轻出生缺陷的影响。举个例子，